scispace - formally typeset
M

Michael T. Stang

Researcher at Duke University

Publications -  88
Citations -  8963

Michael T. Stang is an academic researcher from Duke University. The author has contributed to research in topics: Thyroid cancer & Thyroidectomy. The author has an hindex of 33, co-authored 84 publications receiving 8025 citations. Previous affiliations of Michael T. Stang include Mayo Clinic & University of Pittsburgh.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2522 more
- 21 Jan 2016 - 
TL;DR: In this paper, the authors present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macro-autophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

Impact of Mutational Testing on the Diagnosis and Management of Patients with Cytologically Indeterminate Thyroid Nodules: A Prospective Analysis of 1056 FNA Samples

Yuri E. Nikiforov, +13 more
- 31 Aug 2011 - 
TL;DR: Molecular analysis for a panel of mutations has significant diagnostic value for all categories of indeterminate cytology and can be helpful for more effective clinical management of patients with thyroid nodules.
Journal ArticleDOI

American Thyroid Association Statement on Remote-Access Thyroid Surgery

Eren Berber, +8 more
- 15 Mar 2016 - 
TL;DR: Remote-access thyroidectomy has a role in a small group of patients who fit strict selection criteria, and therefore should be done by surgeons performing a high volume of thyroid and robotic surgery.
Journal ArticleDOI

Optimizing surgical treatment of papillary thyroid carcinoma associated with BRAF mutation

Linwah Yip, +9 more
- 01 Dec 2009 - 
TL;DR: Pre-operative cytologic identification of BRAF mutation has high specificity and may guide the initial extent of thyroidectomy and node dissection in PTC and could have productively altered initial PTC surgical management in 24% of patients.
Journal ArticleDOI

Cost Impact of Molecular Testing for Indeterminate Thyroid Nodule Fine-Needle Aspiration Biopsies

Linwah Yip, +9 more
- 14 Mar 2012 - 
TL;DR: Molecular testing of cytologically indeterminate FNA results is cost saving predominantly because of reduction in two-stage thyroidectomy, and Appropriate use of emerging molecular testing techniques may help optimize patient care, improve resource use, and avoid unnecessary operation.